I/LA25

Maternal Serum Screening, 2nd Edition

This document addresses the steps required to provide reliable screening and reporting using examples of serum markers currently in common use (AFP, hCG, uE3, inhibin A, PAPP-A). Emphasized is first-trimester screening, in which serum markers used are PAPP-A and hCG , and the main ultrasound marker is nuchal translucency. Outcome evaluation, information management, and calculation of risk are also emphasized. 

This document is available in electronic format only.

Member Price: as low as $42.00

Nonmember Price: $140.00
Log in to see your price and add to cart

Publication Details

Chairholder: Sanda Clejan, PhD

Date of Publication: April 28, 2011

ISBN Number: 1-56238-749-9

Order Code PDF: ILA25A2E

Order Code Print: print not available

Edition: Second

Pages: 64

I/LA25 Additional Details

This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.